Tine Pooters
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tine Pooters has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
Ilse Gantois
Department of Biochemistry, McGill University, Montreal, Quebec, Canada
4 shared publicationsBen Vermaercke
Department of Psychology, Laboratory of Biological Psychology, University of Leuven, Leuven, Belgium
2 shared publications- Rudi D'Hooge
Laboratory of Biological Psychology, KU Leuven, Tiensestraat 102, 3000 Leuven, Belgium
2 shared publications Rudi D’hOoge
2 shared publicationsAgnieszka Skalecka
Department of Biochemistry, McGill University, Montreal, Quebec, Canada
1 shared publicationAlec Lindsay Ward Dick
Division of Behavioural Neuroscience, Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Victoria 3010, Australia; Department of Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, 80804 Munich, Germany
1 shared publication
Latest Publications
- 15 May 2017
- Published by Springer Nature in Nature Medicine
- Vol. 23 (6) , 674-677
Metformin ameliorates core deficits in a mouse model of fragile X syndrome
Fragile X syndrome (FXS) is the leading monogenic cause of autism spectrum disorders (ASD). Trinucleotide repeat expansions in FMR1 abolish FMRP expression, leading to hyperactivation of ERK and mTOR signaling upstream of mRNA translation. Here we show that metformin, the most widely used drug for type 2 diabetes, rescues core phenotypes in Fmr1-/y mice and selectively normalizes ERK signaling, eIF4E phosphorylation and the expression of MMP-9. Thus, metformin is a potential FXS therapeutic.
- 15 May 2017
- Published by Springer Nature in Nature Medicine
- Vol. 23 (6) , 674-677
Metformin ameliorates core deficits in a mouse model of fragile X syndrome
Fragile X syndrome (FXS) is the leading monogenic cause of autism spectrum disorders (ASD). Trinucleotide repeat expansions in FMR1 abolish FMRP expression, leading to hyperactivation of ERK and mTOR signaling upstream of mRNA translation. Here we show that metformin, the most widely used drug for type 2 diabetes, rescues core phenotypes in Fmr1-/y mice and selectively normalizes ERK signaling, eIF4E phosphorylation and the expression of MMP-9. Thus, metformin is a potential FXS therapeutic.
- Open Access
- 3 May 2017
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (5) , e0176295
Comparison of the spatial-cognitive functions of dorsomedial striatum and anterior cingulate cortex in mice
Neurons in anterior cingulate cortex (aCC) project to dorsomedial striatum (DMS) as part of a corticostriatal circuit with putative roles in learning and other cognitive functions. In the present study, the spatial-cognitive importance of aCC and DMS was assessed in the hidden-platform version of the Morris water maze (MWM). Brain lesion experiments that focused on areas of connectivity between these regions indicated their involvement in spatial cognition. MWM learning curves were markedly delayed in DMS-lesioned mice in the absence of other major functional impairments, whereas there was a more subtle, but still significant influence of aCC lesions. Lesioned mice displayed impaired abilities to use spatial search strategies, increased thigmotaxic swimming, and decreased searching in the proximity of the escape platform. Additionally, aCC and DMS activity was compared in mice between the early acquisition phase (2 and 3 days of training) and the over-trained high-proficiency phase (after 30 days of training). Neuroplasticity-related expression of the immediate early gene Arc implicated both regions during the goal-directed, early phases of spatial learning. These results suggest the functional involvement of aCC and DMS in processes of spatial cognition that model associative cortex-dependent, human episodic memory abilities.
- 3 May 2017
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (5) , e0176295
Open AccessComparison of the spatial-cognitive functions of dorsomedial striatum and anterior cingulate cortex in mice
Neurons in anterior cingulate cortex (aCC) project to dorsomedial striatum (DMS) as part of a corticostriatal circuit with putative roles in learning and other cognitive functions. In the present study, the spatial-cognitive importance of aCC and DMS was assessed in the hidden-platform version of the Morris water maze (MWM). Brain lesion experiments that focused on areas of connectivity between these regions indicated their involvement in spatial cognition. MWM learning curves were markedly delayed in DMS-lesioned mice in the absence of other major functional impairments, whereas there was a more subtle, but still significant influence of aCC lesions. Lesioned mice displayed impaired abilities to use spatial search strategies, increased thigmotaxic swimming, and decreased searching in the proximity of the escape platform. Additionally, aCC and DMS activity was compared in mice between the early acquisition phase (2 and 3 days of training) and the over-trained high-proficiency phase (after 30 days of training). Neuroplasticity-related expression of the immediate early gene Arc implicated both regions during the goal-directed, early phases of spatial learning. These results suggest the functional involvement of aCC and DMS in processes of spatial cognition that model associative cortex-dependent, human episodic memory abilities.
- 1 February 2016
- Published by Elsevier in Behavioural Brain Research
- Vol. 298 (Pt B) , 134-141
Inability to acquire spatial information and deploy spatial search strategies in mice with lesions in dorsomedial striatum
- 1 February 2016
- Published by Elsevier in Behavioural Brain Research
- Vol. 298 (Pt B) , 134-141
Inability to acquire spatial information and deploy spatial search strategies in mice with lesions in dorsomedial striatum
- 1 October 2015
- Published by Elsevier in Brain Research
- Vol. 1624, 239-252
NMDA receptor binding is reduced within mesocorticolimbic regions following chronic inhalation of toluene in adolescent rats
- 1 October 2015
- Published by Elsevier in Brain Research
- Vol. 1624, 239-252
NMDA receptor binding is reduced within mesocorticolimbic regions following chronic inhalation of toluene in adolescent rats
- 1 September 2015
- Published by Elsevier in Brain Research
- Vol. 1621, 294-308
Telencephalic neurocircuitry and synaptic plasticity in rodent spatial learning and memory
- 1 September 2015
- Published by Elsevier in Brain Research
- Vol. 1621, 294-308
Telencephalic neurocircuitry and synaptic plasticity in rodent spatial learning and memory
- 22 April 2014
- Published by Wiley in Addiction Biology
- Vol. 20 (3) , 500-512
Role of α4- and α6-containing nicotinic receptors in the acquisition and maintenance of nicotine self-administration
Tobacco smoking is a major cause of death and disease and as such there is a critical need for the development of new therapeutic approaches to treat nicotine addiction. Here, we utilize genetic and pharmacological tools to further investigate the nicotinic acetylcholine receptor (nAChR) subtypes that support intravenous self-administration of nicotine. α4-S248F mice contain a point mutation within the α4 nAChR subunit which confers increased sensitivity to nicotine and resistance to mecamylamine. Here, we show that acute administration of mecamylamine (2 mg/kg, i.p.) reduces established nicotine self-administration (0.05 mg/kg/infusion) in wild-type (WT), but not in α4-S248F heterozygous mice, demonstrating a role for α4* nAChRs in the modulation of ongoing nicotine self-administration. Administration of N,N-decane-1,10-diyl-bis-3-picolinium diiodide (bPiDI), a selective α6β2* nAChR antagonist, dose dependently (5 and 10 mg/kg, i.p.) impairs the acquisition of nicotine self-administration and reduces established nicotine self-administration in WT mice when administered acutely (10 mg/kg, i.p.). This was not due to a general reduction in locomotor activity and the same dose of bPiDI did not affect operant responding for sucrose. bPiDI treatment (10 mg/kg, i.p.) also impaired both the acquisition and maintenance of nicotine self-administration in α4-S248F heterozygous mice. This provides further evidence for the involvement of α6β2* nAChRs in the reinforcing effects of nicotine that underlies its ability to support ongoing self-administration. Taken together, selective targeting of α6β2* or α4α6β2* nAChRs may prove to be an effective strategy for the development of smoking cessation therapies.
- 22 April 2014
- Published by Wiley in Addiction Biology
- Vol. 20 (3) , 500-512
Role of α4- and α6-containing nicotinic receptors in the acquisition and maintenance of nicotine self-administration
Tobacco smoking is a major cause of death and disease and as such there is a critical need for the development of new therapeutic approaches to treat nicotine addiction. Here, we utilize genetic and pharmacological tools to further investigate the nicotinic acetylcholine receptor (nAChR) subtypes that support intravenous self-administration of nicotine. α4-S248F mice contain a point mutation within the α4 nAChR subunit which confers increased sensitivity to nicotine and resistance to mecamylamine. Here, we show that acute administration of mecamylamine (2 mg/kg, i.p.) reduces established nicotine self-administration (0.05 mg/kg/infusion) in wild-type (WT), but not in α4-S248F heterozygous mice, demonstrating a role for α4* nAChRs in the modulation of ongoing nicotine self-administration. Administration of N,N-decane-1,10-diyl-bis-3-picolinium diiodide (bPiDI), a selective α6β2* nAChR antagonist, dose dependently (5 and 10 mg/kg, i.p.) impairs the acquisition of nicotine self-administration and reduces established nicotine self-administration in WT mice when administered acutely (10 mg/kg, i.p.). This was not due to a general reduction in locomotor activity and the same dose of bPiDI did not affect operant responding for sucrose. bPiDI treatment (10 mg/kg, i.p.) also impaired both the acquisition and maintenance of nicotine self-administration in α4-S248F heterozygous mice. This provides further evidence for the involvement of α6β2* nAChRs in the reinforcing effects of nicotine that underlies its ability to support ongoing self-administration. Taken together, selective targeting of α6β2* or α4α6β2* nAChRs may prove to be an effective strategy for the development of smoking cessation therapies.
- 1 March 2013
- Published by Elsevier in Behavioural Brain Research
- Vol. 241, 32-37
Increased gait variability in mice with small cerebellar cortex lesions and normal rotarod performance
- 1 March 2013
- Published by Elsevier in Behavioural Brain Research
- Vol. 241, 32-37
Increased gait variability in mice with small cerebellar cortex lesions and normal rotarod performance
- 1 February 2013
- Published by Elsevier in Behavioural Brain Research
- Vol. 239, 72-79
Chronic administration of AFQ056/Mavoglurant restores social behaviour in Fmr1 knockout mice
- 1 February 2013
- Published by Elsevier in Behavioural Brain Research
- Vol. 239, 72-79
Chronic administration of AFQ056/Mavoglurant restores social behaviour in Fmr1 knockout mice